158 related articles for article (PubMed ID: 6214842)
1. T cells in monoclonal gammopathies.
Mellstedt H; Holm G; Pettersson D; Björkholm M; Johansson B; Lindemalm C; Peest D; Ahre A
Scand J Haematol; 1982 Jul; 29(1):57-64. PubMed ID: 6214842
[TBL] [Abstract][Full Text] [Related]
2. T-cell subpopulations in patients with monoclonal gammopathies: essential monoclonal gammopathy, multiple myeloma, and Waldenstrom macroglobulinemia.
San Miguel JF; Caballero MD; Gonzalez M
Am J Hematol; 1985 Nov; 20(3):267-73. PubMed ID: 3933332
[TBL] [Abstract][Full Text] [Related]
3. Imbalances of T-cell subsets in monoclonal gammopathies.
Bergmann L; Mitrou PS; Weber KC; Kelker W
Cancer Immunol Immunother; 1984; 17(2):112-6. PubMed ID: 6331877
[TBL] [Abstract][Full Text] [Related]
4. T-cell subsets in malignant lymphomas and monoclonal gammopathies.
Bergmann L; Mitrou PS; Kelker W; Weber KC
Scand J Haematol; 1985 Feb; 34(2):170-6. PubMed ID: 3156399
[TBL] [Abstract][Full Text] [Related]
5. Multiple myeloma, Waldenström's macroglobulinemia, and benign monoclonal gammopathy: characteristics of the B cell clone, immunoregulatory cell populations and clinical implications.
Mellstedt H; Holm G; Björkholm M
Adv Cancer Res; 1984; 41():257-89. PubMed ID: 6428176
[No Abstract] [Full Text] [Related]
6. [The OKT4/OKT8 ratio in benign monoclonal gammopathies].
La Rosa L; Mattoni C; La Rosa M
Minerva Med; 1988 Dec; 79(12):1049-50. PubMed ID: 2974933
[TBL] [Abstract][Full Text] [Related]
7. Active T rosettes, human autologous T rosettes, OKT8 and OKT4 cells, con A-induced suppressive activity, and autoantibodies: clinical correlations.
Schandené L; Vanden Steen F; Romasco F; Wybran J
Clin Immunol Immunopathol; 1983 Aug; 28(2):147-54. PubMed ID: 6223764
[TBL] [Abstract][Full Text] [Related]
8. [Subsets of T cells in myeloma, macroglobulinemia and benign monoclonal gammopathy: analysis of surface markers defined by monoclonal antibodies and the effect on Ig-synthesis by B cells].
Okagawa K; Iguchi K; Iishi Y; Kosaka M
Nihon Ketsueki Gakkai Zasshi; 1985 Aug; 48(5):1205-13. PubMed ID: 3934898
[No Abstract] [Full Text] [Related]
9. [Studies of peripheral blood lymphocytes subpopulation in multiple myeloma, Waldenström's macroglobulinemia and benign monoclonal gammopathy (author's transl)].
Matsuda S; Kimura H; Tanaka T; Akizuki T; Yoshida H; Uchida T; Kariyone S
Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):485-92. PubMed ID: 99942
[No Abstract] [Full Text] [Related]
10. Detection of anti-histone activity in sera of patients with monoclonal gammopathies.
Shoenfeld Y; el-Roeiy A; Ben-Yehuda O; Pick AI
Clin Immunol Immunopathol; 1987 Feb; 42(2):250-8. PubMed ID: 3100119
[TBL] [Abstract][Full Text] [Related]
11. Functional heterogeneities among concanavalin A-activated OKT4+ and OKT8+ cells by using autologous erythrocyte rosette technique.
Takada S; Ueda Y; Murakawa Y; Suzuki N; Sakane T
J Clin Invest; 1983 Dec; 72(6):2060-71. PubMed ID: 6227636
[TBL] [Abstract][Full Text] [Related]
12. Enumeration of T lymphocytes subsets in autoimmune disease using monoclonal antibodies.
Raeman F; De Cock W; De Beukelaar T; De Cree J; Verhaegen H
Clin Exp Immunol; 1981 Sep; 45(3):475-9. PubMed ID: 6461446
[TBL] [Abstract][Full Text] [Related]
13. [Lymphocyte subpopulations in multiple myeloma. Shift in the helper/suppressor cell relation].
Ludwig H; Fritz E
Acta Med Austriaca; 1982; 9(5-6):215-20. PubMed ID: 6219532
[TBL] [Abstract][Full Text] [Related]
14. Abnormal monoclonal antibody-defined helper/suppressor T-cell subpopulations in multiple myeloma: relationship to treatment and clinical stage.
Mills KH; Cawley JC
Br J Haematol; 1983 Feb; 53(2):271-5. PubMed ID: 6217831
[TBL] [Abstract][Full Text] [Related]
15. T-cell subsets in multiple myeloma. Impact of cytostatic treatment.
Wahlin A; Roos G; Holm J
Blut; 1985 Oct; 51(4):291-5. PubMed ID: 3876858
[TBL] [Abstract][Full Text] [Related]
16. Differential recovery of circulating T cell subsets after nodal irradiation for Hodgkin's disease.
Haas GS; Halperin E; Doseretz D; Linggood R; Russell PS; Colvin R; Barrett L; Cosimi AB
J Immunol; 1984 Feb; 132(2):1026-30. PubMed ID: 6361130
[TBL] [Abstract][Full Text] [Related]
17. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes.
Faure M; Thivolet J
J Clin Immunol; 1982 Jul; 2(3 Suppl):103S-110S. PubMed ID: 6215423
[TBL] [Abstract][Full Text] [Related]
18. T-cell subsets defined by monoclonal antibodies in monoclonal gammopathy of undetermined significance (MGUS).
Cavanna L; Di Stasi M; Fornari F; Civardi G; Binelli F; Buscarini E; Buscarini L
Tumori; 1985 Dec; 71(6):543-6. PubMed ID: 2934880
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of E-rosetting human lymphocytes with OKT11 and other monoclonal antibodies.
Ip SH; Rittershaus CW; Struzziero CC; Hoxie JA; Hoffman RA; Healey KW; Lifter J
Blood; 1982 Sep; 60(3):795-9. PubMed ID: 6980679
[TBL] [Abstract][Full Text] [Related]
20. Membrane phenotype and functional behaviour of T lymphocytes in multiple myeloma: correlation with clinical stages of the disease.
Lauria F; Foa R; Cavo M; Gobbi M; Raspadori D; Giubellino MC; Tazzari PL; Tura S
Clin Exp Immunol; 1984 Jun; 56(3):653-8. PubMed ID: 6235070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
